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Abstract: Background: HIV in-
fected children survive to adoles-
cence because of anti retroviral
therapy, however, only a small
proportion know their diagnosis.
Disclosure is critical to long-term
disease management, yet little is
known about if, how, and when
disclosure takes place and the
barriers associated with it, and its
impact on children in resource-
limited settings.
Objective: This study set out to
determine the process of and bar-
riers to HIV disclosure in children
as well as the immediate impact
of this on children and their care-
givers.
Methods: A cross-sectional study
was done June-July 2016 using a
structured questionnaire, conven-
ience sampling and quantitative
methods at the infectious disease
clinics of National Hospital
Abuja. A sample of 164 caregiv-
ers of HIV positive children aged
5 to 16 years receiving antiretro-
viral therapy for at least one year
were enrolled.
Results: Prevalence of full disclo-
sure was 24.5%, partial 22.7%
with overall prevalence of 47.2%.
Main barrier to disclosure was
child’s age and fear of informing
others. The impact of disclosure on
caregivers was relief in 45.5% but
emotional and difficult for others.
Immediate reactions by children
were sadness; tearfulness and
worry in 28.6%, some showed no
reaction while others even ex-
pressed relief. On a longer term,
disclosure had several effects.
Main predictors of disclosure on
regression were the child’s age and
caregiver’s opinion on disclosure.
Conclusion: The prevalence of full
disclosure is low and several barri-
ers affect disclosure. Caregiver’s
and HCWs need empowerment
and support with culturally appro-
priate skills and platforms to deal
with the barriers, process and
impact of disclosure.
CC –BY
Introduction
Children with Human Immunodeficiency Virus (HIV)
are surviving to adolescence and adulthood because of
the increasing long-term use of antiretroviral therapy.
Disclosure to the child about his HIV status is an impor-
tant component of long-term disease management, yet
there is limited knowledge of when and how this takes
place in developing countries as well as the barriers and
impact of disclosure on children.1, 2
Nigeria with a HIV prevalence of 3.2 % has the second
highest numbers of people living with HIV/AIDS in the
world.3,4 An estimated 3.4 million people are living with
the virus including 380,000 children aged 0 to 14 years.3
Disclosure simply means to “reveal, to make known, to
make public or share an information on an issue.”
5
.Disclosure in the context of HIV could be about in-
forming children about their own HIV status or the HIV
status of their caregivers.2 In this context however, dis-
closure refers to the former. Disclosure can be full
where the child is informed that he has HIV/AIDS or
partial in which case the child is informed that he has a
chronic illness for which he needs to be on treatment for
a long time. It’s prevalence in children and adolescents
from sub-Saharan African studies ranges between 1.7-
56.7%.1-8 These are generally low considering the bene-
fits of disclosure which have been reported to result im-
proved adherence to medications, higher CD4 counts,
higher self-esteem and fewer symptoms of depression.6-8
Additionally, disclosed adolescents may be better able to
seek social support, have improved coping skills and
improved communication with caregivers 9,10 as well as
practice safer sexual practices to prevent secondary
transmission.8 Disclosure to children and adolescents
also reduces the stress, burden and depression parents
feel by hiding the diagnosis from their children.1, 11Care
givers often require a step by step guide or support from
HCW or others on how to conduct disclosure. Lack of
these skills often lead to non- disclosure.1,14
Despite all these identified benefits, the prevalence of
disclosure is low due to several barriers. In rural Zam-
bia,12 Mweeba et al reported the fear of stigma and dis-
crimination to the child as a significant barrier to disclo-
sure. Other reported barriers include the fear of the
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child’s reaction, the fear of blame on the parents and the
reaction of others in the community if the child is unable
to keep the secret. 2, 13-19The age when the child will be
old and mature enough to be able to understand what the
mother disclosed was a significant barrier reported
across several studies.2,11,15,16,20-22
There is limited literature on the impact of HIV status
disclosure on children and little is known about the qual-
ity of life thereafter, In a survey in South Africa involv-
ing caregivers of children aged 4-17 years, 61% of the
children showed no reaction on disclosure while 36%
were sad and withdrawn and 10% were worried and
tearful. 15Similarly, Mutumba in Uganda reported that
Adolescents in their cohort had both negative and posi-
tive reactions. Negative reactions included hopelessness,
fear of death, sadness, anger, and even suicidal consid-
erations.16 On the contrary, a small number reported
positive reactions such as relief and happiness at learn-
ing their diagnosis or discovering the family secret.
Reactions to disclosure were closely related to knowl-
edge about HIV and ART, respondent’s health status at
the time of disclosure, prior experiences with HIV-
infected persons, age, and gender.16 For instance, re-
spondents who were well, described their initial reac-
tions to disclosure as shock and disbelief, while adoles-
cents who were frequently ill were not surprised at the
diagnosis, and even experienced relief at learning the
cause of their illness.
Disclosure is crucial to long-term disease management,
several reports have associated it with improved medica-
tion adherence, self esteem and improved communica-
tion with caregivers.6-10 This study aims to determine the
process of and barriers to HIV disclosure in children as
well as determine the immediate impact of disclosure on
children and their caregivers.
Methodology
Study design: A primary study with a cross-sectional
design was conducted over 6 weeks in June - July 2016
using convenience non- randomized sampling and quan-
titative methods. A structured pre –piloted questionnaire
prepared in English with closed-ended questions and pre
-coded responses in some sections was used. Questions
were structured into five sections to cover: socio-
demographic characteristics, disclosure and its proc-
esses, facilitators and barriers to disclosure as well as
type of support received during disclosure as well as
immediate impact of disclosure.
Interpreters were used were necessary and the question-
naire applied to those who found filling it challenging. It
was administered in a private room away from the chil-
dren to ensure confidentiality and avoid unplanned dis-
closure.
Study Participants and setting: Participants were re-
cruited from the paediatrican tiretroviral clinic of Na-
tional Hospital Abuja, a tertiary center that serves as a
referral hospital not only to the district hospitals within
town but also from neighboring states and beyond.
These participants were caregivers of HIV positive chil-
dren aged 5 to 16 years receiving antiretroviral therapy
for at least one year who had read the patient informa-
tion sheet and consented to participate in the study.
Sample size: As this was a prevalence study, the confi-
dence interval formula for surveys was used to deter-
mine the estimated sample size of 180. Ethical approvals
were obtained from ethical review boards of both the
University of Sheffield, UK and the National Hospital
Abuja Nigeria.
Data Management: Respondents were assigned a
unique identifier and the questionnaire was anonymised
with no personal identifiers collected. The data was ex-
tracted from the questionnaires by the researcher,
cleaned and validated and stored electronically in a
folder in a password-encrypted computer. This was done
simultaneously as the data was being collected. Analysis
was done within a month following completion of data
collection. The paper forms of the data were stored away
in a securely locked cupboard and will be destroyed 6
months after the completion of the study.
Information, verbal consent and confidentiality
A month prior to the onset of the study, poster contain-
ing information about the study was posted on the notice
boards of both clinics. The purpose was to sensitize
caregivers about the study before it started. Subse-
quently, Participant information sheet were also pro-
vided highlighting the aims and importance of the study.
The researchers assured them of full confidentiality and
anonymity as well as data protection. Additionally, par-
ticipants were informed of their right to withdraw from
the study
Results
Although a sample size of 180 was projected, 170 were
enrolled because of industrial action in the hospital. Of
the 170 participants that were eligible, 164 participants
consented to participate giving a response rate of
96.5 %.
Socio-demographic characteristics
The children’s age ranged between 1-16 years with a
mean of 10.5 years (SD 3.58) while the mean age at
diagnosis was 3.5 years (SD 2.98) with a range of 0- 13
years.  The mean age at enrolment into care was 3.8
years (SD 3.89). The majority of children had been on
ART for more than 4 years (119; 72.6%), 3-4 years in
22 (13.4%) and for at least one year in 9 (5.5%). The
mean duration on ART was 4.4 years (SD 1.12). The
male to female ratio of 1.6:1 and 70% of the children
were either in primary or Junior Secondary School. Ma-
jority of the caregivers,162 (98.8%) lived in the same
household as the child. Forty-three (30.7%) of biological
fathers had died compared to 6 (4.3%) biological
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mothers. Fathers had higher levels of education and
more professional jobs compared to the mothers.
Prevalence of disclosure
The prevalence of formal disclosure was 47. 2% of
which full disclosure was done in 24.5%, and partial
Disclosure was done in 22.7%. About 52.8% of the par-
ticipants did not have any formal disclosure. The mean
age of the children at full disclosure was 11.87 SD
2.065. Details of these have been reported earlier.23
Disclosure process
Disclosure was considered a process by 62 (81%) of the
caregivers as they reported informing the children
gradually about the chronic illness they had before even-
tually telling them that they had HIV/AIDS. However,
for 15 (19%) caregivers, disclosure was considered a
one-time event as they informed the children of their
status at one sitting. Caregivers along with HCW (28;
36.1%) or both parents together (24; 31.2%) mainly un-
dertook the process of disclosure (table 1).
Support prior to disclosure was received by 40 (51.9%)
caregivers while 37 (48.1%) reported not receiving any
support. Of those that were supported, 38 (95%) re-
ported that the process was explained to them. Support
was provided by Healthcare workers (HCW) in 36
(90.0%) cases, by a support group in 3(7.5%), by family
members in 1(2.5%).
Table 1: Responsible person for disclosure (n=77)
Barriers to disclosure
One hundred and sixty three responders identified sev-
eral reasons for not disclosing or for delaying disclosure
to children. The single most common reason was the
fear that the child will inform others (51; 31.3%), fol-
lowed by the child was too young in 30 (18.4%). Addi-
tional barriers identified include fears that the parent
will be blamed for transmission, fear of the child’s re-
sentment, feeling unprepared for the questions that will
follow disclosure and feeling unprepared for the disclo-
sure process. A combination of reasons were also identi-
fied such as child was too young and can inform others
20 (12.3%). (Table 2)
Impact of disclosure
Impact on caregiver
Of the 77 caregivers that either partially or fully dis-
closed to their children, 35 (45.5%) reported feeling
Responsible person Frequency Percent (%)
Father 9 11.7
Mother 10 13.0
Parents together 24 31.2
HCW 5 6.5
Parents and HCW 28 36.1
Others 1 1.3
Total 77 100
Barriers Frequency
(n=163)
Percent
(%)
Fears of child informing others 51 31.3
Child too young 30 18.4
Fear of child’s resentment 7 4.3
Feeling unprepared for questions 12 7.4
Feeling unprepared for disclosure 14 8.6
Parental fear of blame for transmis-
sion
8 4.8
Combined reasons
Too young and may inform others
Too young and fear child’s condition
may deteriorate
Too young, may inform others and
condition may deteriorate
20
12
9
12.3
7.4
5.5
Total 163 100
relieved after disclosing, 9 (11.7%) described the proc-
ess as very emotional, 7 (9.1%) felt it was a realistic
thing to do while 8 (10.4%) felt it was both emotional
and difficult. Other caregivers reported a combination of
feelings or responses such as empowering, practical and
valuable.
Impact on the child
The immediate reactions to disclosure by the children
are shown in Table 3
Table 2: Identified barriers to disclosure
Table 3: Immediate reaction of children following disclosure
(n=77)
There were mixed reactions, as some were tearful and
cried (15; 19.5%), some were relieved (5; 6.5%) and
others showed no reaction (22; 28.6%).
When the caregivers were asked about the effect that
disclosure has had on the children over time, several
responses were obtained (Table 4) with the majority
reporting that disclosure improved medication adherence
(44; 57.1%) while 4 (5.2%) refused medications after
disclosure.
Bivariate Analysis
To identify if there was an association between disclo-
sure and some independent variables, bivariate analysis
was done. There was no statistically significant differ-
ence between those that disclosed and those that did not
in relation to gender (Pearson’s χ 2 1.676, P 0.196), re-
ligion (Pearson’s χ 2 0.32, P 0.858), ethnicity (χ 2 for trend
0.690, P 0.406) or if a child had any siblings (Pearson’s
χ 2 2.402, P 0.121). However there was a significant rela-
Response Frequency Percent %
Tearful or cried 15 19.5
Withdrawn and unresponsive 15 19.5
Relief 5 6.5
Anger 2 2.5
Inquisitive and asked questions 4 5.2
Sad, tearful and worried 7 9.1
Surprised 7 9.1
No reaction 22 28.6
Total 77 100
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tionship between disclosure and the child’s level of edu-
cation ( χ 2 for trend26.710, P <0.001), support for disclo-
sure ( χ 24.399, P 0.036) and if caregiver held the opinion
that children should have disclosure done (Pearson’s χ 2
30.174, P<0.001)(Table 5).
An independent sample T test was also done to find any
association between the age of the child at his last birth-
day and disclosure. The mean age at disclosure was
11.87 (SD 3.290) while for the non disclosed 9.07(SD
3.154). The mean difference was 3.158 P <0.001; SE
0.507; 95% CI 2.156-4.159.
Table 4: Effect of disclosure on children and adolescents
(N=77)
Table 5: Relationship between disclosure and some
independent   variables
Response Frequency Percentage
Coping better in school 10 13.0
Taking medications regularly
(adherence)
44 57.1
Refused medications 4 5.2
Protection of self and others 4 5.2
Multiple responses
Coping better and improved medi-
cation adherence
Improved adherence, positive out-
look to life and self protection
Coping better, improved adherence
and a positive outlook to life.
5
6
4
6.5
7.8
5.2
Total 77 100
Independent Variable
Disclosure Chi
square
X2
P ValueYes (%) No (%)
Socioeconomic status (n=163)
Upper
Middle
Lower
24(48.0)
27(42.0)
26(53.0)
26(52.0)
37(58,0)
23(47.0)
0.246# 0.620
Mothers Education (n=151)
University
National Diploma
Secondary school
Primary school
No formal education
18(72.0)
18(39.0)
25(48.0)
6(27.0)
4(67.0)
7(28.0)
28(61.0)
27(52.0)
16(73.0)
29(33.0)
2.818# 0.093
Duration on ART (years) n=163
At least 1
1-2
2-3
3-4
>5
0(0.0)
5(71.0)
2(29.0)
10(46.0)
60(51.0)
9(100.0)
2(29.0)
5(71.0)
12(54.0)
58(49.0)
4.360# 0.037*
Do you think the child should be told his status n=162
Yes
No
75(58.0)
1(3.2)
55(42.0)
30(96.8)
30.174$
<0.001*
Support for disclosure =163
Yes
No
40(53.0)
37(42.0)
35(47.0)
51(58.0)
4.399$
0.036*
YES
NO
73(51.0)
4(21.0)
71(49.0)
15(79.0)
5.917$ 0.015*
Would you recommend disclosure to other parents n=163
Characteristic Coeffi-
cient
B
Standard
Error
Wald Signifi-
cance
Odds
ratio
95% Confidence
Interval.
Lower        Upper
Age of the child 2.83 0.62 20.837 0.000 1.328 1.176 1.499
Caregivers perception
on disclosure
3.649 1.049 12.090 0.001 38.424 4.914 2.542
Support for disclosure 0.153 0.398 0.148 0.700 1.166 0.534 2.542
Constant -6.42 1.244 26.989 0.000 0.002
Binary Logistic regression
Independent variables found to be significantly associ-
ated with disclosure were further subjected to a binary
logistic regression model (Table 6). In the final model,
only the age of the child (P<0.001, 95% CI 1.176-1.499)
and the caregiver’s opinion (P = < 0.001, 95% CI 4.914-
2.542) on whether disclosure should be done or not were
significant.  The odds of being disclosed per year of
increasing age were 1.35 times the odds of not being
disclosed i.e as the age increased, odds of being dis-
closed increased by 0.35 (35%). Similarly, for one unit
change (opinion child should be told), the odds of being
disclosed to are 38.4 times the odds of not being dis-
closed.
Discussion
This primary cross-sectional study, set out to determine
the process of HIV disclosure to children, identify barri-
ers influencing disclosure as well as explore the immedi-
ate impact of disclosure on children.
Most of the Caregivers (81%) perceived disclosure as a
gradual process, informing children they had a chronic
illness requiring long-term treatment to encourage medi-
cations while waiting not only for the child to get older
but also to prepare themselves for disclosure. However,
19% considered it a one-time event, informing the chil-
dren at one sitting. Vaz et al19 reported that even though
parents reported disclosure as a gradual event, the chil-
dren saw it as a discrete event.  Madibba et al20 found
that biological parents approached disclosure as a proc-
ess after dealing with their own personal fears over the
child’s diagnosis while non-biological caregivers often
blurted out the diagnosis impulsively often during mo-
ments of emotional outbursts. This study did not explore
children’s opinion on disclosure and did not find any
difference in the type of disclosure between different
caregivers.
In this study, both parents (31.2%), the parent or care-
giver assisted by the HCW (36.1%) or the mother alone
conducted disclosure most of the time. Support on how
to conduct disclosure was provided to 51.9% of the care-
givers and 95% of them were confident that the process
was explained to them. Caregiver support for disclosure
seemed statistically significant towards disclosing, how-
ever, contrary to expectations; in the final regression
model this was not sustained. This effect may be better
assessed in a larger study. Several reports from resource-
poor countries have identified that parents did not feel
Table 6: Logistic regression model showing predictors of disclosure
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adequately prepared for disclosure, due to limited skills1,
14,19,24 and most requested the support of HCWs. In Tan-
zania,25 where disclosure was mainly carried out by
HCWs, the need for training and provision of simple to
follow step-by-step guidelines was recommended. Sev-
eral disclosure models appropriate to developing coun-
tries26-29 have been developed to provide the much-
needed guidance by HCWs as the guideline by WHO
30does not provide a step-by-step approach. The Inte-
grated Nigerian National guideline for HIV prevention
treatment and care does have a section on disclosure but
it is very brief and inadequate.
The most common reasons caregivers identified as barri-
ers to disclosure were the fear that the child may inform
others and being too young. This is understandable be-
cause in Nigeria, the extended family system is very
vibrant with the large family living in one big compound
and the children sharing meals and playing together.
Should the young child share the “secret” of HIV status
with friends it almost automatically discloses parental
status to the rest of the family and friends leading to
stigma, discrimination and loss of respect. Other barriers
identified by the caregivers included feeling unprepared
to disclose, fear of blame for transmission as well as
concern for the child’s physical, mental and emotional
health. Several other studies reported similar findings
from Africa2,16,20,21,31,32,38. Additionally, Madibba21 iden-
tified barriers such as caregivers not knowing what, how
and the right time to tell as well as the fear of associat-
ing the diagnosis with death and dying.
Clearly, many of these barriers can be addressed by pro-
vision of early counseling by HCWs and provision of
support services as well as mass media education on
stigma reduction.
Disclosure had an impact both in the short and long term
on the child and the caregivers.  It brought a feeling of
relief to a majority (45.5%) of caregivers and for others,
it was very emotional and difficult. This is not unex-
pected as parents often carry a heavy burden of guilt
especially with mother to child transmission of HIV.
The immediate reactions to disclosure by the children
were mixed and probably age and maturity related. Pos-
sibly, the majority of those that showed no reaction
might be younger children who are yet to comprehend
what they are being told. Some of the children expressed
surprise while others expressed relief. A small propor-
tion were inquisitive and asked questions. Similar find-
ings were described in other studies.15, 21,22 There were
no reports of hopelessness or suicidal ideations in this
study compared to reports by Mutumba.16 Clearly, there
is a need for the person conducting disclosure to be pre-
pared on how to handle the  multiple ways these chil-
dren can react. As such the need for training and retrain-
ing on disclosure strategies and responses.
On a longer term, many caregivers expressed that disclo-
sure had helped the children improve on medication
adherence some were coping better in school and had a
more positive outlook on life.  Caregivers also expressed
that disclosure had empowered the adolescents to protect
themselves and others.  In the report by Brown et al,2
caregivers reported improvement in adherence by up to
63.6%.  Other authors reported that disclosure reduces
the children’s anxiety, allows them to communicate bet-
ter with family and peers as well as reducing the impact
of stigma.20,21, 25
Although there are limited studies on potential negative
consequences of full disclosure, Lesch et al11 showed
that there was no evidence that disclosure had a long
term negative impact on children’s psychological and
emotional health outcomes. Additionally, Phuma et al17
explored the experiences of disclosed 10-14-year-olds
and concluded "children move from being worried about
taking life-long medications to acceptance of their diag-
nosis. They also expressed unhappiness that their par-
ents delayed disclosure." Inston33also reported that chil-
dren that are not disclosed to tend to internalize prob-
lems and become poor communicators. On the contrary,
Zhao et al 34 found that there was no difference in psy-
chological measures between disclosed and undisclosed
children. Clearly, there is a need for more studies to de-
termine these effects in African Children.
No matter the argument, the subject of disclosure of
HIV status to children is a very sensitive one. As
pointed out by some researchers,35- 36although clinical
guidelines can enhance the quality of clinical decisions
and the consistency of care, it is essential for HCW to
consider the culture in which the patient is immersed, as
culture is the basis for understanding social interactions,
behaviours, and the meaning of actions.37 This is very
relevant to the African society, where parents are often
seen as authority figures and communication between a
parent and child is often unidirectional and directive.
This may explain the wide disparities between the more
developed nations38-39 with disclosure rates of up to 75%
and low resource settings. Due to such traditional hierar-
chies in African settings, parents are likely to experience
some loss of control and respect from their children
when they disclose.  It is essential for the HCWs to be
sensitive and recognize this while trying to teach the
parents new sets of communication skills that will pro-
vide a platform for open discussion with their children.
The study has several identified strengths. A sample of
164 participants and a response rate of 96.5% is a good
number with sufficient power for a cross-sectional
study. Secondly, the study was conducted in a national
referral centre for Pediatric HIV care based in the Nige-
rian capital city. This provides a good representation of
participants from different ethnic groups and social
classes. Thirdly, the questionnaire was piloted prior to
sample collection. This allowed adjustment of questions
to make them clearer to participants.
The study also had several limitations. Like all cross-
sectional designs, there was potential for selection and
information bias. The research was conducted in a treat-
ment centre and one of the inclusion criteria was being
on ART for at least one year. Being on ART may have a
compounding effect on disclosure, even though in this
study, the duration on ART was not found to be signifi-
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cantly associated with disclosure. Additionally, because
of the cross-sectional design, only associations could be
ascertained and not causal relationships.
Secondly, because of industrial action that took place at
the hospital, the desired sample size of 180 could not be
reached and 164 caregivers were interviewed.
It is recommended that the Nigerian National guidelines
should be reviewed to provide adequate, step-by-step
age-appropriate guide to healthcare workers on disclo-
sure. Pictorial Job aids should also be developed to
capture the various stages of disclosure. These guide-
lines should be disseminated to all treatment centres and
used to train HCWs. Support groups should be empow-
ered with adequate, appropriate knowledge and skills to
support each other.
Conflict of interest: None
Funding: None
References
1.      Vreeman RC, Gramelstacker
AM, Gisore PO, Scantoli ML,
Nyandiko WM.   Disclosure of
HIV status to children in re-
source limited settings. A sys-
tematic review. J Interl AIDS
Soci 2013,16:184-66.
2.      Brown, BJ, Oladokun RE,
Osinusi K, Ochigbo S, Ade-
wole IF et al. Disclosure of
HIV status to infected children
in a Nigerian HIV care pro-
gram. AIDS Care 2011; 23(9):
1053-1058.
3.      United Nations Program on
HIV/AIDS UNAIDS. Country
Profile; Nigeria. [Online] Ge-
neva: UNAIDS. 2016. Avail-
able from http://
www.unaids.org/en/
regionscountries/countries/
nigeria
(Accessed 2016 March 10)
4.      Federal Republic Of Nigeria.
National Agency For Control
Of HIV/AIDS. Global AIDS
Response. Country Progress
Report 2015. NACA. Abuja
Nigeria.
5.      Olaleye DO, Harry TO,
Odaibo GN. The virology and
dynamics of the epidemic. In:
Adeyi O, Kanki P, odutolu O,
Idoko J, editors. AIDS in Ni-
geria A Nation on the thresh-
old. Harvard centre for popula-
tion and development studies.
2006.
6. Bachanas PJ, Kullgren KA,
Schwartz KS, Lanier B,
McDaniel JS, Smith J, et al.
Predictors of psychological
adjustment in school-age chil-
dren infected with HIV. J Pedi-
atr Psychol. 2001; 26(6): 343-
52.
7.      Blasini I, Chantry C, Cruz C,
Ortiz L, Salabarria I, Scalley
N, et al. Disclosure model for
pediatric patients living with
HIV in Puerto Rico:  design,
implementation, and evalua-
tion. J Dev Behav Pediatr.
2004; 25(3): 181.
8.      Hammami N, Nostlinger C,
Hoeree T, Lefevre P, Jonck-
heer T, Kolsteren P. Integrat-
ing adherence to highly active
antiretroviral therapy into chil-
dren’s daily lives: a qualitative
study. Pediatr. 2004; 114(5):
591-7.
9.      Gerson AC, Joyner M,
Fosarelli P, Butz A, Wissow
L, Lee S, et al. Disclosure of
HIV diagnosis to children:
when, where, why, and how. J
Pediatr Health Care. 2001; 15
(4): 161-7.
10.    Sopena S, Evangeli M, Dodge
J, Melvin D.  Coping and psy-
chological adjustment in ado-
lescents with vertically ac-
quired HIV. AIDS Care. 2010;
22(10): 1252-8.
11.    Lesch A, Swartz L, Kagee A,
Moodley K, Kafaar Z, Myer
L, et al. Paediatric HIV/AIDS
disclosure: towards a develop-
mental and process-oriented
approach. AIDS Care .
2007;19(6):811–6.
12.   Mweemba M, Musheke MM,
Michelo C, Halwiindi H,
Mweemba O, Zulu JM.
“When am I going to stop
taking the drug?” Enablers,
barriers and processes of dis-
closure of HIV status by care-
givers to adolescents in a rural
district. BMC Public Health .
2015;15(1):1028.
13.   Turisini M, Nyandiko W,
Ayaya S, Marete I, Mwangi
A, Chemboi Vet al. The
prevalence of disclosure of
HIV status to HIV-infected
children in Western Kenya. J
Pediatr Infect Dis
Soc. 2013:136-43.
14.   Abebe W, Teferra S. Disclo-
sure of diagnosis by parents
and caregivers to children
infected with HIV: Preva-
lence associated factors and
perceived barriers in Addis
Ababa, Ethiopia. AIDS Care .
2012;24(9):1097–102.
15.    Mahloko JM, Madiba SE.
Disclosing HIV diagnosis to
children in Odi district, South
Africa: Reasons for disclo-
sure and non-disclosure. Afri-
can J Prim Heal Care Fam
Med . 2012 ;4(1): 234-241.
16.    Mutumba M, Musiime V,
Tsai AC, Byaruhanga J, Ki-
weewa F, Bauermeister JA,
et al. Disclosure of HIV
Status to Perinatally Infected
Adolescents in Urban
Uganda: A Qualitative Study
on Timing, Process, and Out-
comes. J Assoc Nurses AIDS
Care. 2015; 472-484.
17. Phuma-Ngaiyaye EE, Dartey
AF. Experiences of children
living with HIV and AIDS
following their diagnosis dis-
closure in Mzuzu, Malawi.
Vulnerable Child Youth
Studies. 2015; 10(4):357-365.
18.    Namasopo-Oleja M S,
Bagenda D, Ekirapa-Kiracho
E. Factors affecting disclo-
sure of serostatus to children
attending Jinja Hospital Pae-
diatric HIV clinic, Uganda.
Afr Health Sci. 2015;15
(2):344–51.
311
19.    Vaz LME, Maman S, Eng E,
Barbarin OA, Tshikandu T,
Behets F. Patterns of Disclo-
sure of HIV Status to Infected
Children in a Sub-Saharan
African Setting. J Dev Behav
Pediatr. 2011;32(4):307–15.
20.    Madiba S. Disclosing HIV to
Infected Children in South
Africa in the Era of HAART:
A Grounded Theory Study on
the Process, Reasons and Out-
comes of Disclosure. World J
AIDS. 2012;02(04):319–29.
21.    Madiba S, Mokwena K. Care-
givers’ Barriers to Disclosing
the HIV Diagnosis to Infected
Children on Antiretroviral
Therapy in a Resource-
Limited District in South Af-
rica: A Grounded Theory
Study. AIDS Res Treat. 2012;9
(9):1–10.
22.    Mandalazi P, Bandawe C,
Umar E. HIV Disclosure: Pa-
rental dilemma in informing
HIV infected Children about
their HIV Status in Malawi.
Malawi Med J. 2014;26
(4):101–4.
23.    Mariya Mukhtar-Yola. Should
Children Know Their HIV
Status? Barriers And Impact
Of Disclosure To Children In
Abuja, Nigeria. A dissertation
submitted in partial fulfillment
of the requirements for the
degree of Master of Public
Health at the school of Health
and Related Research. The
University of Sheffield, UK.
September 2016.
24.    Oberdorfer P, Puthanakit T,
Sirisanthana T, et al. Disclo-
sure of HIV/AIDS diagnosis to
HIV-infected children in Thai-
land. J Paediatr Child
Health. 2006;42 (5):283–288.
25.    Midtbø V, Shirima V, Skovdal
M, Daniel M. How disclosure
and antiretroviral therapy help
HIV-infected adolescents in
sub-Saharan Africa cope with
stigma. Afr J AIDS. 2012;11
(3):261–71.
26.   Lowenthal ED, Marukutira C.
Disclosure of HIV status to
HIV- infected children in ar-
eas with high HIV prevalence.
J. Paediatr. Infect. Dis. Soc.
2013; 2(2): 144-146.
27.   Cantrell K, Patel N, Mandrell
B, Grissom S. Pediatric Hiv
Disclosure: A Process-
Oriented Framework. Aids
Educ Prev. 2013;25(4):302–
14.
28.   Evengelli M, Kayce A. A
model of caregiver paediatric
HIV disclosure decision mak-
ing. Psychology Health and
Medicine. 2016;(21): 338-353.
29.   Vreeman RC, Nyandiko WM,
Ayaya SO, Walumbe EG,
Marrero DG, Inui TS. The
perceived impact of disclosure
of pediatric HIV status on
pediatric antiretroviral therapy
adherence, child well-being,
and social relationships in a
resource-limited setting. AIDS
Patient Care STDS. 2010; 24
(10): 639-49.
30.   World Health Organization.
Guideline on HIV disclosure
counseling for children up to
12 years of age. Geneva:
World Health Organization;
2011
31.    Kallem S, Renner L, Musie G,
Paintsil E. Prevalence and
Pattern of Disclosure of HIV
Status in HIV-Infected Chil-
dren in Ghana. AIDS Behav.
2011;(15):1121-1127
32.   Atwiine B, Kiwanuka J, Mus-
inguzi N, Atwine D, Haberer
JE. Understanding the role of
age in HIV disclosure rates
and patterns for HIV-infected
children in  southwestern
Uganda. AIDS Care. 2015;27
(4):424–30.
33.    Instone SL. Perceptions of
Children With HIV Infection
When Not Told for So Long:
Implications for Diagnosis
Disclosure. J Paediatric
Health Care. 2000;14(5):235-
243.
34.    Zhao J, Li X, Qiao S, Zhao
G, Zhang L, Stanton B.  Par-
enteral HIV disclosure: from
perspectives of children af-
fected by HIV in Henan
China. AIDS Care. 2015; 27
(4): 416-23
35.    Chew J, Beng AL, Mun S.
Parental Concerns About
Disclosure of a Child’s HIV/
AIDS Status in Singapore.
Soc Work Health Care.
2012;51(1):5-21.
36.    Woolf SH, Grol R, Hutchin-
son A, Eccles M & Grim-
shaw J. Potential benefits,
limitations, and harms of
clinical guidelines. British
Medical J; 1999; (318)527–
530.
37.    Thorne C, Newell ML, Botet
FA, et al. Older children and
adolescents surviving with
vertically acquired HIV in-
fection. J Acquir Immune
Defic Syndr.2002; 29:396–
401. [PubMed]
38.   Wiener L, Mellins CA, Mar-
hefka S, Battles HB. Disclo-
sure of HIV diagnosis to chil-
dren: history, current re-
search, and future directions.
J Dev Behav Pediatr. 2007;
28(2): 155-66.
39.    Mellins CA, Brackis-Cott E,
Dolezal C, Abrams EJ. The
role of psychosocial and fam-
ily factors in adherence to
antiretroviral treatment in
human immunodeficiency
virus-infected children. Pedi-
atr Infect Dis J.  2004; 23
(11): 35-41.
